Delivery Order SPE2DB22D3301-SPE2DB25FY8DM
- Not listed
- The Defense Logistics Agency awarded a $11,087.60 delivery order to AmerisourceBergen Drug Corp for Padcev 30 mg vials, with an ultimate completion date of August 8, 2025. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order was awarded on July 18, 2025, as part of AmerisourceBergen's broader engagement with the federal government for pharmaceutical supply. This delivery order falls under AmerisourceBergen's substantial...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,345.32, is for the delivery of PADCEV 30 MG vials. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 30, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PADCEV 30 MG VIALS. The contract has a potential value of $24,999.30 and a completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which supports military treatment programs and facilities with pharmaceuticals and medical supplies. This delivery order is issued under...
- This federal contract award, valued at $19,999.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of PADCEV 30 MG VIALS, a medical product, with a completion date of December 10, 2024. The contract is a Delivery Order under a Firm Fixed Price type, and there is no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,695.90 contract is for the delivery of PADCEV 20 MG VIAL 1S medical supplies. The contract is non-set-aside, indicating open competition. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,175.20 Firm Fixed Price Delivery Order contract is for the supply of PADCEV 30 MG VIALS, a medical product, with a completion date of February 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- The Defense Logistics Agency awarded a $9,735 delivery order to Amerisourcebergen Drug Corporation for 4561499385 PADCEV 30 MG VIALS. The firm fixed price order is being carried out under the Prime Vendor Pharmaceutical program, with performance taking place in Conshohocken, Pennsylvania through August 3, 2023. As a leading distributor of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will deliver the cancer treatment vials to DLA distribution centers for...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $9,999.72 order is for the supply of PADCEV 30 mg vials, a pharmaceutical product, with a completion date of February 12, 2024. Amerisourcebergen Drug Corp has received numerous prior federal contract awards to provide pharmaceuticals, medical supplies, and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,338.30, is for the delivery of PADCEV 30 MG VIALS and has a completion date of December 26, 2023. The contract is a Firm Fixed Price Delivery Order and was not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PADCEV 30 MG vials. The order has a potential value of $116,823.84 and a completion date of June 1, 2023. Amerisourcebergen Drug Corp is a prime contractor that regularly supplies pharmaceuticals, medical supplies, and distribution services to support DLA Troop Support Medical facilities and programs. This delivery order...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY8DMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,543.80 to AmerisourceBergen Drug Corp for the supply of PADCEV 30 mg vials. This contract is a firm fixed-price delivery order with no set-aside designation, issued competitively on July 21, 2025, and scheduled for completion by August 11, 2025. The products will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's Indefinite Delivery Contract with DLA functions as a comprehensive global pharmaceutical support vehicle enabling supply chain flexibility for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a major for-profit pharmaceutical distributor, AmerisourceBergen demonstrates consistent capability in fulfilling federal procurement requirements through competitive bidding and maintains a significant presence in the Defense Logistics Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 7/21/25 |